Principal Financial Group Inc Teva Pharmaceutical Industries LTD Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$15.81 - $18.96 $279,789 - $335,535	-17,697 Reduced 16.48%	89,719 $1.62 Million
Q2 2024 Jul 29, 2024	SELL	$12.78 - $17.4 $102,636 - $139,739	-8,031 Reduced 6.96%	107,416 $1.75 Million
Q1 2024 Apr 29, 2024	SELL	$10.67 - $14.43 $41,506 - $56,132	-3,890 Reduced 3.26%	115,447 $1.63 Million
Q4 2023 Feb 07, 2024	SELL	$8.12 - $10.63 $67,071 - $87,803	-8,260 Reduced 6.47%	119,337 $1.25 Million
Q3 2023 Nov 02, 2023	SELL	$7.48 - $10.7 $92,041 - $131,663	-12,305 Reduced 8.8%	127,597 $1.3 Million
Q2 2023 Aug 07, 2023	BUY	$7.2 - $9.47 $210,931 - $277,433	29,296 Added 26.49%	139,902 $1.05 Million
Q1 2023 May 09, 2023	SELL	$8.36 - $11.37 $19,855 - $27,003	-2,375 Reduced 2.1%	110,606 $978,000
Q4 2022 Feb 09, 2023	BUY	$7.95 - $9.48 $35,703 - $42,574	4,491 Added 4.14%	112,981 $1.03 Million
Q3 2022 Nov 09, 2022	SELL	$6.86 - $11.95 $179,752 - $313,125	-26,203 Reduced 19.45%	108,490 $875,000
Q2 2022 Aug 10, 2022	SELL	$7.38 - $10.4 $37,888 - $53,393	-5,134 Reduced 3.67%	134,693 $1.01 Million
Q1 2022 May 09, 2022	BUY	$7.33 - $9.39 $23,067 - $29,550	3,147 Added 2.3%	139,827 $1.31 Million
Q4 2021 Feb 09, 2022	SELL	$7.9 - $10.19 $135,872 - $175,257	-17,199 Reduced 11.18%	136,680 $1.1 Million
Q3 2021 Nov 09, 2021	BUY	$8.38 - $10.18 $18,712 - $22,731	2,233 Added 1.47%	153,879 $1.5 Million
Q2 2021 Aug 10, 2021	BUY	$9.9 - $11.56 $226,452 - $264,423	22,874 Added 17.76%	151,646 $1.5 Million
Q1 2021 May 10, 2021	BUY	$10.34 - $12.81 $99,584 - $123,373	9,631 Added 8.08%	128,772 $1.49 Million
Q4 2020 Feb 08, 2021	SELL	$8.61 - $11.04 $110,397 - $141,554	-12,822 Reduced 9.72%	119,141 $1.15 Million
Q3 2020 Nov 06, 2020	SELL	$8.57 - $12.69 $148,963 - $220,577	-17,382 Reduced 11.64%	131,963 $1.19 Million
Q2 2020 Aug 05, 2020	SELL	$8.12 - $13.12 $5,838 - $9,433	-719 Reduced 0.48%	149,345 $1.84 Million
Q1 2020 May 12, 2020	BUY	$6.69 - $13.45 $172,287 - $346,377	25,753 Added 20.72%	150,064 $1.35 Million
Q4 2019 Feb 05, 2020	BUY	$6.53 - $10.72 $243,497 - $399,738	37,289 Added 42.85%	124,311 $1.22 Million
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $278,228 - $433,603	-45,167 Reduced 34.17%	87,022 $599,000
Q2 2019 Aug 12, 2019	SELL	$8.12 - $15.72 $23.1 Million - $44.8 Million	-2,850,899 Reduced 95.57%	132,189 $1.22 Million
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $5.93 Million - $7.61 Million	380,496 Added 14.62%	2,983,088 $46.8 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $24.7 Million - $40.3 Million	1,691,013 Added 185.5%	2,602,592 $40.1 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $16.8 Million - $20.5 Million	797,295 Added 697.64%	911,579 $19.6 Million
Q2 2018 Aug 13, 2018	BUY	$16.77 - $24.71 $56,850 - $83,766	3,390 Added 3.06%	114,284 $0
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $15,962 - $21,120	-957 Reduced 0.86%	110,894 $1.9 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $86,010 - $146,286	-7,659 Reduced 6.41%	111,851 $2.12 Million
Q3 2017 Nov 02, 2017	BUY	$15.41 - $32.17 $1.84 Million - $3.84 Million	119,510	119,510 $2.1 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$979 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$825 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$787 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$657 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$603 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account